Norgine is a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for over a century. Our commitment to transforming people’s lives drives everything we do and our European experience, fully integrated infrastructure and exceptional partnership approach enables us to quickly apply creative solutions to bring life-changing medicines to patients that they may not otherwise be able to access. Norgine is proud to have helped 24 million patients around the world in 2021 and generated €505 million in net product sales, a growth of 10% over 2020. Norgine has a direct presence in 16 European countries, as well as Australia and New Zealand. We also have a strong global network of partnerships in non-Norgine markets. We are a flexible and fully integrated pharmaceutical business, with manufacturing (Hengoed, Wales and Dreux, France), third party supply networks and significant product development capabilities, in addition to our sales and marketing infrastructure. This enables us to acquire, develop and commercialise specialist and innovative products that make a real difference to the lives of patients around the world. In 2012, Norgine established Norgine Ventures, a complementary business which supports innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit www.norgineventures.com.
View Top Employees from NorgineWebsite | http://www.norgine.com |
Revenue | $300 million |
Funding | $12.1 million |
Employees | 981 (981 on RocketReach) |
Founded | 1906 |
Address | Antonio Vivaldistraat 150, Amsterdam, North Holland 1083, NL |
Phone | +31 20 567 0900 |
Fax | +31 20 567 0999 |
Technologies |
JavaScript,
HTML,
PHP
+75 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceutical, Pharmaceuticals, Health Care, Healthcare |
Web Rank | 3 Million |
Keywords | Pharmaceutical Solutions, Prescription, Medical Treatment, Healthcare Technologies, Therapeutic Activities, Drug Development And Manufacturing, Clinical Research, Patient Care, Pharmaceutical Development |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Norgine employee's phone or email?
The Norgine annual revenue was $300 million in 2024.
Christopher Bath is the CEO of Norgine.
981 people are employed at Norgine.
Norgine is based in Amsterdam, North Holland.
The NAICS codes for Norgine are [3254, 32541, 32, 325].
The SIC codes for Norgine are [28, 283].